These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10412898)

  • 1. Valproate metabolites in the rat brain--regional distribution in various brain areas.
    Darius J; Meyer FP; Bergsträsser E; Ebermann E; Andreas K
    Eur J Drug Metab Pharmacokinet; 1999; 24(1):97-104. PubMed ID: 10412898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of unsaturated metabolites of valproate in human and rat brain--pharmacologic relevance?
    Adkison KD; Ojemann GA; Rapport RL; Dills RL; Shen DD
    Epilepsia; 1995 Aug; 36(8):772-82. PubMed ID: 7635096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.
    Semmes RL; Shen DD
    Epilepsia; 1991; 32(2):232-41. PubMed ID: 2004628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment.
    Löscher W; Nau H
    J Pharmacol Exp Ther; 1983 Sep; 226(3):845-54. PubMed ID: 6411902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of phenytoin and carbamazepine on serum concentrations of mono-unsaturated metabolites of valproic acid.
    Kondo T; Otani K; Hirano T; Kaneko S; Fukushima Y
    Br J Clin Pharmacol; 1990 Jan; 29(1):116-9. PubMed ID: 2105099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent distribution volumes of total and unbound valproate in guinea-pigs: consequence of non-linear plasma protein binding.
    Yu HY; Shen YZ
    Biopharm Drug Dispos; 1996 Apr; 17(3):237-47. PubMed ID: 8983398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid: metabolite concentrations in plasma and brain, anticonvulsant activity, and effects on GABA metabolism during subacute treatment in mice.
    Löscher W; Nau H
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):20-31. PubMed ID: 6810778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.
    Löscher W; Fisher JE; Nau H; Hönack D
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1067-78. PubMed ID: 2506334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-column gas chromatographic-mass spectrometric assay for metabolic profiling of valproate in brain tissue and serum.
    Darius J
    J Chromatogr B Biomed Appl; 1996 Jun; 682(1):67-72. PubMed ID: 8832426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: correlation with neural tube defect formation in the mouse.
    Nau H
    Teratology; 1986 Feb; 33(1):21-7. PubMed ID: 3090732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. II. Influence of phenobarbital comedication.
    Löscher W; Nau H; Wahnschaffe U; Hönack D; Rundfeldt C; Wittfoht W; Bojic U
    Epilepsy Res; 1993 Jun; 15(2):113-31. PubMed ID: 8370349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do structural properties explain the anticonvulsant activity of valproate metabolites? A QSAR analysis.
    Bello-Ramírez AM; Carreón-Garabito BY; Nava-Ocampo AA
    Epilepsia; 2002 May; 43(5):475-81. PubMed ID: 12027907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparations.
    Kassahun K; Baillie TA
    Drug Metab Dispos; 1993; 21(2):242-8. PubMed ID: 8097692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative transfer of valproic acid and of an active metabolite into brain and liver: possible pharmacological and toxicological consequences.
    Löscher W; Nau H
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):192-202. PubMed ID: 6435554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits.
    Yokogawa K; Iwashita S; Kubota A; Sasaki Y; Ishizaki J; Kawahara M; Matsushita R; Kimura K; Ichimura F; Miyamoto K
    Pharm Res; 2001 Sep; 18(9):1320-6. PubMed ID: 11683247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of alpha-fluorinated valproic acid in mouse brain and serum and its effect on synaptosomal gamma-aminobutyric acid levels in comparison to valproic acid.
    Tang W; Palaty J; Abbott FS
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1163-72. PubMed ID: 9316822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of valproic acid uptake by isolated rat brain microvessels.
    Naora K; Shen DD
    Epilepsy Res; 1995 Oct; 22(2):97-106. PubMed ID: 8777904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid has temporal variability in urinary clearance of metabolites.
    Reith DM; Andrews J; McLaughlin D
    Chronobiol Int; 2001 Jan; 18(1):123-9. PubMed ID: 11247111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant activity of metabolites of valproic acid.
    Löscher W
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):158-63. PubMed ID: 6784685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid and active unsaturated metabolite (2-en): transfer to mouse liver following human therapeutic doses.
    Nau H; Loscher W
    Biopharm Drug Dispos; 1985; 6(1):1-8. PubMed ID: 3921077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.